A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension

NCT00788541 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

197

Enrollment

INDUSTRY

Sponsor class

Stopped Project cancellation

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Anecortave Acetate Sterile Suspension, 6 mg/mL
DRUG: Anecortave Acetate Sterile Suspension, 3.75 mg/mL
DRUG: Anecortave Acetate Sterile Suspension, 96 mg/mL
DRUG: Anecortave Acetate Sterile Suspension, 60 mg/ML
OTHER: Anecortave Acetate Vehicle

Sponsor

Alcon Research